Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ANTX
#3609
AN2 Therapeutics, Inc. Common Stock
1.1
0
+1.85%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.85%
Changement Mensuel
-7.56%
Evolution sur 6 mois
-3.51%
Changement Annuel
+0.92%
Clôture Précédente
1.0
8
Open
1.1
0
Bid
Ask
Low
1.1
0
High
1.1
0
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
ANTX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
29.88 M
30.1 M
30.18 M
27.33 M
27.4 M
—
Valuation ratios
Enterprise value
-1.53 M
20.14 M
21.04 M
10.77 M
16.8 M
68.74 M
Price to earnings ratio
-0.55
-0.8
-0.9
-0.85
-1.11
-3.67
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
0.49
0.84
0.96
0.9
1.28
3.97
Price to book ratio
0.07
0.5
0.12
0.1
0.13
0.86
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.13
-0.08
-0.13
0.09
0.14
0.01
Return on equity %
0.15
-0.09
-0.15
0.09
0.16
0.01
Return on invested capital %
—
-1 397.79
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.75
10.07
9.29
11.67
12.52
43.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.4
-0.18
-0.35
-0.25
-0.21
-0.99
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.13
2.8
2.23
2.08
2.05
9.17
Net current asset value per share
3.27
2.89
2.31
2.24
2.11
9.56
Tangible book value per share
2.94
2.74
2.44
2.28
1.99
9.46
Working capital per share
2.94
2.6
2.07
2.05
1.95
8.66
Book value per share
2.94
2.74
2.44
2.28
1.99
9.46
Nouvelles
AN2 Therapeutics nomme Sarah Williams au poste de responsable comptable principal
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
FDA clears IND for epetraborole trial in mycobacterium abscessus
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
AN2 Therapeutics (ANTX) : La directrice financière Day vend des actions pour 8883€
An2 therapeutics (ANTX): cfo Day sells $8883 in shares
Le CSO d’AN2 Therapeutics vend des actions pour 6.507€
An2 therapeutics CSO prior sells $6507 in stock
Eizen, AN2 Therapeutics COO, sells $25k in ANTX stock
An2 therapeutics chief development officer sells $9k in stock
AN2 Therapeutics s’associe à GSK pour développer des traitements contre la tuberculose